DCCR clinical trials

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

This study looks at the long-term safety of a medicine called DCCR for people with Prader-Willi syndrome. It's for those who have already taken part in a previous DCCR study.